Indications
Baltic Sea TM Project Overview
Extensor Bio Inc. is pioneering a novel, preventive therapy for Dupuytren’s Contracture (DD), a debilitating fibroproliferative disorder affecting hand function. Patients with DD experience progressive contractures of the fingers and palmar tissue, which severely impact daily tasks and quality of life. Currently, no approved preventive therapies exist. Surgical options and enzymatic injections (e.g., Xiaflex®) are only used in late-stage disease, with high costs, invasiveness, and recurrence rates.
The Baltic Sea Project is a first-in-class, minimally invasive, preventive treatment aimed at modulating early inflammatory pathways involved in DD pathogenesis. This approach is informed by our team’s recent peer-reviewed work on the role of inflammatory markers in Dupuytren’s.
RED SEATM PROJECT OVERVIEW
Extensor Bio Inc. is developing a groundbreaking multi biomarker panel that addresses one of aging’s mostdebilitating manifestations: osteoarthritis (OA). Our technology not only predicts OA progression—enabling earlier intervention and personalized treatment approaches—but also establishes a platform for identifying age-related biomarkers across multiple conditions.
By leveraging the intersection of aging research and precision medicine, the approach of the Red Sea Project integrates comprehensive biological data analysis with advanced machine learning to identify OA biomarker signatures that could revolutionize how we manage age-related joint deterioration and restoration of joint function.